Insights from animal models on the immunogenetics of leprosy - A review

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue SUPPL.1, 2012, Pages 197-208

  Adams, Linda B ^a   Pena, Maria T ^a,b   Sharma, Rahul ^a,b   Hagge, Deanna A ^c   Schurr, Erwin ^d   Truman, Richard W ^a  

^a HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Anandaban Leprosy Hospital   (Nepal)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Armadillos; Experimental animal models; IL 12; Knockout mice; PARK2; Toll like receptor

Indexed keywords

ANIMAL; ARMADILLO; ARTICLE; DISEASE MODEL; GENETICS; IMMUNOGENETICS; IMMUNOLOGY; LEPROSY; MICROBIOLOGY; MOUSE; MYCOBACTERIUM LEPRAE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARMADILLOS; DISEASE MODELS, ANIMAL; IMMUNOGENETIC PROCESSES; LEPROSY; MICE; MYCOBACTERIUM LEPRAE;

ANIMALIA; ARMADILLO; DASYPODIDAE; MUS; MYCOBACTERIUM LEPRAE;

EID: 84871478190     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000900028     Document Type: Article

References (83)

1. Adams JE, Pena MT, Gillis TP, Williams DL, Adams LB, Truman RW 2005. Expression of nine-banded armadillo (Dasypus novemcinctus) interleukin-2 in E. coli. Cytokine 32: 219-225.
2. Adams LB, Job CK, Krahenbuhl JL 2000. Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice. Infect Immun 68: 5462-5465.
3. Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, Nelson S 1995. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 171: 400-405.
4. Adams LB, Scollard DM, Ray NA, Cooper AM, Frank AA, Orme IM, Krahenbuhl JL 2002. The study of Mycobacterium leprae infection in interferon-gamma gene-disrupted mice as a model to explore the immunopathologic spectrum of leprosy. J Infect Dis 185 (Suppl. 1): S1-S8.
5. Akira S, Takeda K 2004. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
6. Alcais A, Alter A, Antoni G, Orlova M, Nguyen VT, Singh M, Vanderborght PR, Katoch K, Mira MT, Vu HT, Ngyuen TH, Nguyen NB, Moraes M, Mehra N, Schurr E, Abel L 2007. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 39: 517-522.
7. Alter A, Grant A, Abel L, Alcais A, Schurr E 2011. Leprosy as a genetic disease. Mamm Genome 22: 19-31.
8. Azouaou N, Gelber RH, Abel K, Sasaki DT, Murray LP, Locksley RM, Mohagheghpour N 1993. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line. Int J Lepr Other Mycobact Dis 61: 398-405.
9. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162: 3504-3511.
10. Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, LaVoie MJ 2009. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 18: 4317-4328.
11. Berrington WR, Hawn TR 2007. Mycobacterium tuberculosis, macrophages and the innate immune response: does common variation matter? Immunol Rev 219: 167-186.
12. Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, Burdick A, Sarno EN, Wagner M, Rollinghoff M, Rea TH, Colonna M, Stenger S, Bloom BR, Eisenberg D, Modlin RL 2003. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301: 1527-1530.
13. Bochud PY, Hawn TR, Aderem A 2003. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 170: 3451-3454.
14. Bochud PY, Hawn TR, Siddiqui MR, Saunderson P, Britton S, Abraham I, Argaw AT, Janer M, Zhao LP, Kaplan G, Aderem A 2008. Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis 197: 253-261.
15. Bochud PY, Sinsimer D, Aderem A, Siddiqui MR, Saunderson P, Britton S, Abraham I, Tadesse Argaw A, Janer M, Hawn TR, Kaplan G 2009. Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur J Clin Microbiol Infect Dis 28: 1055-1065.
16. Boisson-Dupuis S, El Baghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J, Samarina A, Grant AV, Janniere L, El Hafidi N, Hassani A, Nolan D, Najib J, Camcioglu Y, Hatipoglu N, Aydogmus C, Tanir G, Aytekin C, Keser M, Somer A, Aksu G, Kutukculer N, Mansouri D, Mahdaviani A, Mamishi S, Alcais A, Abel L, Casanova JL 2011. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco and Turkey. PloS ONE 6: e18524.
17. Cardoso CC, Pereira AC, Brito-de-Souza VN, Duraes SM, Ribeiro-Alves M, Augusto CNJ, Francio AS, Vanderborght PR, Parelli FP, Alter A, Salgado JL, Sampaio EP, Santos AR, Leide Wr, Oliveira M, Sarno EN, Schurr E, Mira MT, Pacheco AG, Moraes MO 2011a. TNF-308G. A single nucleotide polymorphism is associated with leprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study. J Infect Dis 204: 1256-1263.
18. Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO 2011b. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity and disease outcome. Future Microbiol 6: 533-549.
19. Chehl S, Ruby J, Job CK, Hastings RC 1983. The growth of Mycobacterium leprae in nude mice. Lepr Rev 54: 283-304.
20. Colston MJ, Hilson GR 1976. Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature 262: 399-401.
21. Cooper AM, Adams LB, Dalton DK, Appelberg R, Ehlers S 2002a. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol 10: 221-226.
22. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM 2002b. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168: 1322-1327.
23. Cottle LE 2011. Mendelian susceptibility to mycobacterial disease. Clin Genet 79: 17-22.
24. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177: 1416-1420.
25. Dawson PJ, Colston MJ, Fieldsteel AH 1983. Infection of the congenitally athymic rat with Mycobacterium leprae. Int J Lepr Other Mycobact Dis 51: 336-346.
26. de Diego JL, Gerold G, Zychlinsky A 2007. Sensing, presenting and regulating PAMPs. Ernst Schering Found Symp Proc 3: 83-95.
27. Deretic V 2010. Autophagy in infection. Curr Opin Cell Biol 22: 252-262.
28. Ebenezer GJ, Arumugam S, Job CK 2002. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice. Int J Lepr Other Mycobact Dis 70: 245-249.
29. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immun 2: 561-572.
30. Fukutomi Y, Matsuoka M, Minagawa F, Toratani S, McCormick G, Krahenbuhl J 2004. IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae. Int J Lepr Other Mycobact Dis 72: 16-26.
31. Gros P, Skamene E, Forget A 1981. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127: 2417-2421.
32. Hagge DA, Marks VT, Ray NA, Dietrich MA, Kearney MT, Scollard DM, Krahenbuhl JL, Adams LB 2007. Emergence of an effective adaptive cell mediated immune response to Mycobacterium leprae is not impaired in reactive oxygen intermediate-deficient mice. FEMS Immunol Med Microbiol 51: 92-101.
33. Hagge DA, Ray NA, Krahenbuhl JL, Adams LB 2004. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages. J Immunol 172: 7771-7779.
34. Hagge DA, Saunders BM, Ebenezer GJ, Ray NA, Marks VT, Britton WJ, Krahenbuhl JL, Adams LB 2009. Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am J Pathol 174: 1379-1389.
35. Heldwein KA, Fenton MJ 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 4: 937-944.
36. Iwasaki A, Medzhitov R 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
37. Jacobs M, Brown N, Allie N, Gulert R, Ryffel B 2000. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100: 494-501.
38. Job CK, Drain V, Truman R, Deming AT, Sanchez RM, Hastings RC 1992. The pathogenesis of leprosy in the nine-banded armadillo and the significance of IgM antibodies to PGL-1. Indian J Lepr 64: 137-151.
39. Job CK, Drain V, Williams DL, Gillis TP, Truman RW, Sanchez RM, Deming AT, Hastings RC 1991. Comparison of polymerase chain reaction technique with other methods for detection of Mycobacterium leprae in tissues of wild nine-banded armadillos. Lepr Rev 62: 362-373.
40. Job CK, Kirchheimer WF, Sanchez RM 1982. Tissue response to lepromin, an index of susceptibility of the armadillo to M. leprae infection - a preliminary report. Int J Lepr Other Mycobact Dis 50: 177-182.
41. Job CK, Kirchheimer WF, Sanchez RM 1983. Variable lepromin response to Mycobacterium leprae in resistant armadillos. Int J Lepr Other Mycobact Dis 51: 347-353.
42. Job CK, Sanchez RM, Hastings RC 1985a. Effect of repeated lepromin testing on experimental nine-banded armadillo leprosy. Indian J Lepr 57: 716-727.
43. Job CK, Sanchez RM, Hastings RC 1985b. Manifestations of experimental leprosy in the armadillo. Am J Trop Med Hyg 34: 151-161.
44. Job CK, Sanchez RM, McCormick GT, Hastings RC 1985c. First lesion in experimental armadillo leprosy. Indian J Lepr 57: 71-77.
45. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI 2007. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524.
46. Kaneko H, Yamada H, Mizuno S, Udagawa T, Kazumi Y, Sekikawa K, Sugawara I 1999. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. Lab Invest 79: 379-386.
47. Kang TJ, Chae GT 2001. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31: 53-58.
48. Khader SA, Gopal R 2010. IL-17 in protective immunity to intracellular pathogens. Virulence 1: 423-427.
49. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175: 788-795.
50. Kirchheimer WF, Sanchez RM 1981. Intraspecies differences of resistance against leprosy in nine-banded armadillos. Lepr India 53: 525-530.
51. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 183: 1461-1472.
52. Levy L, Ji B 2006. The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr Rev 77: 5-24.
53. Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, Klein E, Flynn JL 2010. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 62: 340-350.
54. Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Dore C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427: 636-640.
55. Misch EA, Berrington WR, Vary JC Jr, Hawn TR 2010. Leprosy and the human genome. Microbiol Mol Biol Rev 74: 589-620.
56. Misch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, Siddiqui MR, Kaplan G, Hawn TR 2008. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2: e231.
57. Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN 2007. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Br J Dermatol 157: 273-283.
58. Pattyn SR 1965. Comparative behaviour of a strain of M. leprae in 5 different mouse strains and in thymectomized mice. Zentralbl Bakteriol, Parasit, Infektionskr Hyg 197: 256-258.
59. Pena MT, Adams JE, Adams LB, Gillis TP, Williams DL, Spencer JS, Krahenbuhl JL, Truman RW 2008. Expression and characterization of recombinant interferon gamma (IFN-gamma) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages. Cytokine 43: 124-131.
60. Rees RJ 1966. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature 211: 657-658.
61. Reisner FKD 1943. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberculosis 47: 549-574.
62. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 184: 1999-2006.
63. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ 2001. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 193: 239-246.
64. Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, Schumann RR, Oskam L 2009. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 199: 1816-1819.
65. Schurr E, Buschman E, Malo D, Gros P, Skamene E 1990. Immunogenetics of mycobacterial infections: mouse-human homologies. J Infect Dis 161: 634-639.
66. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL 2006a. The continuing challenges of leprosy. Clin Microbiol Rev 19: 338-381.
67. Scollard DM, Joyce MP, Gillis TP 2006b. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. Clin Infect Dis 43: e19-22.
68. Scollard DM, Lathrop GW, Truman RW 1996. Infection of distal peripheral nerves by M. leprae in infected armadillos: an experimental model of nerve involvement in leprosy. Int J Lepr Other Mycobact Dis 64: 146-151.
69. Scollard DM, Truman RW 1999. The armadillo leprosy model with particular reference to lepromatous neuritis. In Handbook of Animal models of infection, Academic Press, New York, p. 331-335.
70. Shepard CC 1960. The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112: 445-454.
71. Shepard CC 1962. Multiplication of Mycobacterium leprae in the foot-pad of the mouse. Int J Lepr 30: 291-306.
72. Soroosh P, Doherty TA, So T, Mehta AK, Khorram N, Norris PS, Scheu S, Pfeffer K, Ware C, Croft M 2011. Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations. J Exp Med 208: 797-809.
73. Storrs EE, Williams RJ 1968. A study of monozygous quadruplet armadillos in relation to mammalian inheritance. Proc Natl Acad Sci USA 60: 910-914.
74. Taulman JF, Robbins LW 1996. Recent range expansion and distributional limits of the nine-banded armadillo (Dasypus novemcinctus) in the United States. J Biogeography 23: 635-648.
75. Torrado E, Cooper AM 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 21: 455-462.
76. Truman RW, Krahenbuhl JL 2001. Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 69: 1-12.
77. Truman RW, Morales MJ, Shannon EJ, Hastings RC 1986. Evaluation of monitoring antibodies to PGL-1 in armadillos experimentally infected with M. leprae. Int J Lepr Other Mycobact Dis 54: 556-559.
78. Truman RW, Sanchez RM 1993. Armadillos: models for leprosy. Lab Animal 22: 28-32.
79. Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST 2011. Probable zoonotic leprosy in the southern United States. N Engl J Med 364: 1626-1633.
80. van de Vosse E, van Dissel JT, Ottenhoff TH 2009. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 9: 688-698.
81. Ware CF 2005. Network communications: lymphotoxins, LIGHT and TNF. Annu Rev Immunol 23: 787-819.
82. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277-279.
83. Yogi Y, Nakamura K, Inoue T, Kawatsu K, Kashiwabara Y, Sakamoto Y, Izumi S, Saito M, Hioki K, Nomura T 1991. Susceptibility of severe combined immunodeficient (SCID) mice to Mycobacterium leprae: multiplication of the bacillus and dissemination of the infection at early stage. Nihon Rai Gakkai Zasshi 60: 139-145.